I-Arbidol - ezifanayo

Ukuze kuvikelwe, kanye nokwelapha amagciwane we-etiology ehlukene, izidakamizwa ezikhethekile zisetshenziswa. Omunye wemithi ethandwa kakhulu phakathi kwabo ngu-Arbidol. Odokotela bakhetha le remedy ngenxa yomsebenzi wayo wokuzivuselela owedlule. Kodwa, ngeshwa, lesi sidakamizwa asifaneleki wonke umuntu futhi ngezinye izikhathi kuyadingeka ukufaka esikhundleni se-Arbidol ngento ethile - izifanekiselo zihanjiswa emaqenjini amaningana wezidakamizwa ngenani elikhulu lamagama.

Ama-Analogues we-Arbidol

Ukuhlelwa kwemikhiqizo efanayo noma efanayo emzimbeni kukhulu kakhulu:

Njengoba kunikezwe ukuthi isitifiketi sokudayiswa kwezidakamizwa ezihlongozwayo sekuphelile iminyaka engu-7 eyedlule (ngo-2007), ezinye izidakamizwa zavela emakethe yemithi ebizwa ngokuthi i-analogue kanye nokushintshwa kuka-Arbidol ngesithako esifanayo esisebenzayo, kodwa ngaphansi kwamagama ahlukene: i-Arpetol ne-Imustat.

Ake sicabangele ngokuningiliziwe ngezizukulwane ze-ejenti echazwe.

Kagocel noma i-Arbidol?

Ngaphambi kokuqhubeka nokukhetha umuthi, kubalulekile ukutadisha indlela yokwenza ngayo. Ngokuqondene namagama atholakalayo, ahluke ngokuphelele.

Ngakho-ke, iKagocel, ikakhulukazi, i-immunomodulator enomphumela oveziwe. Umphumela owenzayo ufana no-Anaferon. Lezi zidakamizwa zisusa uhlelo lokuzivikela komzimba ukukhiqiza i-interferon engapheli ngokwemali ekhuphukile yokulwa nokutheleleka.

I-Arbidol, ngaphezu kokuzikhumbuza umzimba, inomthelela we-antiviral. Into esebenzayo ivimbela ukuthintana kwamagciwane we-pathogenic ashintshiwe ngamaseli anempilo.

Naphezu kokuthi izinkomba zokusetshenziswa kulezi zidakamizwa ziyafana, zisebenza ngezindlela ezehlukene futhi isinqumo sokuthi ukusebenzisa imithi eyodwa kufanele ithathwe udokotela.

Ingavirin noma i-Arbidol - engcono?

Ukukhetha phakathi kwalezi zidakamizwa ezimbili, kufanele uthole ukubonisana nodokotela.

Iqiniso liwukuthi nakuba i-Arbidol ine-anti-infiratory and immunostimulating activity, iyisidakamizwa esincane esinomphumela onomthelela omncane. I-Ingavirin iyisisombululo esinamandla kakhulu se-influenza A no-B, kanye nezinkinga ezibangelwa izifo eziphefumulayo neziphefumulayo. Isidakamizwa sisiza ngokushesha i-Arbidol futhi sikhiqiza umphumela ozinzile, kodwa kuyingozi ngempela.

I-Analog Arbidol Remantine

Eqinisweni, i-Remantadine ayikwazi ukubizwa ngokuthi i-analogue yalesi sidakamizwa, ngoba ayinayo umphumela wokuzivivinya umzimba. I-agent iyisisetshenziswa esisebenzayo se-antiviral esivimbela ukwanda kwamaseli we-pathogenic.

Kumele kuqashelwe ukuthi i-Remantadine ine-hepatotoxicity ebuthakathaka kanye neziguli ezinesibindi esisebenza kahle kufanele zithathwe ngokucophelela, njengoba lesi sidakamizwa sigxiliswa ngalesi sitho.

Uma ukhuluma ngokusebenza kahle, kungcono ukubhekana nezinambuzane zomkhuhlane kanye ne- ARVI ngosizo lwe-Remantadine, ikakhulukazi ezigabeni zokuqala zesifo.

Aflubin noma Arbidol - okungcono?

Uma ucabanga ngalezi zidakamizwa ezimbili, kudingeka uqaphele ukuthi u-Aflubin ungumuthi we-homeopathic. Ngaphezu kwalokho, akukhiqizi umphumela we-antiviral. Inhloso yokuthatha amaconsi noma amaphilisi ukugqugquzela izixhumanisi zokuzivikela kanye nokwandisa ukwenziwa kwe-interferon. I-Aflubin nayo inomthelela obuthakathaka wokulwa nokuvuvukala ne-antipyretic, isusa ukukhukhumeza futhi ikhuthaza ukuxoshwa komzimba, ihlukanisa kancane i-phlegm ehlukene.